These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10921326)

  • 1. [Multiple exostoses].
    Toguchida J; Nagayama S
    Nihon Rinsho; 2000 Jul; 58(7):1473-8. PubMed ID: 10921326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
    Stickens D; Brown D; Evans GA
    Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From gene to disease; hereditary multiple exostoses].
    Wuyts W; Bovée JV; Hogendoorn PC
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
    Wuyts W; Van Hul W
    Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses.
    Raskind WH; Conrad EU; Matsushita M; Wijsman EM; Wells DE; Chapman N; Sandell LJ; Wagner M; Houck J
    Hum Mutat; 1998; 11(3):231-9. PubMed ID: 9521425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
    Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
    Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
    Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
    Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses.
    Philippe C; Porter DE; Emerton ME; Wells DE; Simpson AH; Monaco AP
    Am J Hum Genet; 1997 Sep; 61(3):520-8. PubMed ID: 9326317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
    McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
    Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses.
    Park KJ; Shin KH; Ku JL; Cho TJ; Lee SH; Choi IH; Phillipe C; Monaco AP; Porter DE; Park JG
    J Hum Genet; 1999; 44(4):230-4. PubMed ID: 10429361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.
    Chen WC; Chi CH; Chuang CC; Jou IM
    J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes.
    Stickens D; Clines G; Burbee D; Ramos P; Thomas S; Hogue D; Hecht JT; Lovett M; Evans GA
    Nat Genet; 1996 Sep; 14(1):25-32. PubMed ID: 8782816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
    Hall CR; Cole WG; Haynes R; Hecht JT
    Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.
    Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT
    J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of hereditary multiple exostoses in the Chinese.
    Xu L; Xia J; Jiang H; Zhou J; Li H; Wang D; Pan Q; Long Z; Fan C; Deng HX
    Hum Genet; 1999; 105(1-2):45-50. PubMed ID: 10480354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlation in hereditary multiple exostoses.
    Francannet C; Cohen-Tanugi A; Le Merrer M; Munnich A; Bonaventure J; Legeai-Mallet L
    J Med Genet; 2001 Jul; 38(7):430-4. PubMed ID: 11432960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas.
    Pedrini E; De Luca A; Valente EM; Maini V; Capponcelli S; Mordenti M; Mingarelli R; Sangiorgi L; Dallapiccola B
    Hum Mutat; 2005 Sep; 26(3):280. PubMed ID: 16088908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.
    McCormick C; Duncan G; Goutsos KT; Tufaro F
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):668-73. PubMed ID: 10639137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation screening of the EXT genes in patients with hereditary multiple exostoses in Taiwan.
    Shi YR; Wu JY; Hsu YA; Lee CC; Tsai CH; Tsai FJ
    Genet Test; 2002; 6(3):237-43. PubMed ID: 12490068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.